C ardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United States, with an overall economic burden in excess of $440 billion annually. 1, 2 Data from previous studies suggest that the incidence of CVD has been decreasing over time, [3][4][5][6][7] in association with increasing public health emphasis on the prevention and treatment of modifiable risk factors such as hypertension and hypercholesterolemia. [8][9][10][11] [12] [13] However, several studies indicate that improvements in CVD incidence are lagging in certain subgroups, including women and blacks. [3][4][5][6] The degree to which these trends may be attributable to differences between subgroups in the relative contribution of traditional risk factors to incident CVD is not known. To better understand changes over time in the contribution of risk factors to incident CVD in the population at large, as well as in important subgroups, we examined the proportion of CVD risk attributable to traditional risk factors in a large biracial sample of men and women living in the community with longitudinal data available and outcomes surveillance spanning over 2 decades.
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Method Study Sample
The study design and sampling of the Atherosclerosis Risk in Communities (ARIC) study has been described (see the online-only Data Supplement).
14 Of all 15 792 participants who were enrolled in ARIC at the first examination, a total of 13 541 participants (56% women, 26% black) contributed any person observations for the current analyses. Specifically, a total of 8240 participants had no known CVD (coronary heart disease, heart failure, or previous cerebrovascular event), had no missing data on traditional cardiovascular risk factors (ie, obesity, hypertension, diabetes mellitus, hypercholesterolemia, and smoking status), and were aged 52 to 66 years at examination 1 (1987-1989) . The number of participants from the study sample who, because of aging, were similarly 52 to 66 years and free of CVD at the subsequent exams was 8915 (examination 2, [1990] [1991] [1992] , 8467 (examination 3, [1993] [1994] [1995] , and 6884 (examination 4, [1996] [1997] [1998] . Institutional review boards approved the original study protocol at each ARIC site. Participants all provided written informed consent, and study procedures were in accordance with institutional guidelines regarding the protection of human subjects.
Clinical Assessment
We used data collected from each examination to define presence of the following traditional risk factors: obesity (body mass index ≥30 kg/m 2 ), hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or taking antihypertensive medication), hypercholesterolemia (total cholesterol ≥200 mg/ dL or taking cholesterol lowering medication), diabetes mellitus (fasting glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, or report of clinical diagnosis or treatment of diabetes mellitus), and current smoking status (self-reported active smoking within 1 year before the examination). Individuals identified as having hypertension or diabetes mellitus at a given examination were considered as having hypertension or diabetes mellitus, respectively, at all subsequent exams. Otherwise, individuals with missing covariate data at a subsequent examination were coded as missing that variable for that particular examination. All participants were followed through December 31, 2008 for the incidence of cardiovascular events (coronary heart disease, heart failure, stroke) or CVD death, ascertained according to previously-defined criteria (see the online-only Data Supplement).
Statistical Analyses
At each of the exams 1 through 4 (ie, the 'baseline' exams), we estimated the population attributable risk (PAR) % of each primary risk exposure (obesity, hypertension, diabetes mellitus, hypercholesterolemia, and smoking status) for the 10-year incidence of CVD using a method that is considered internally valid when adjusted relative risks must be used to account for possible confounding (see the online-only Data Supplement). 15 We performed all PAR calculations using the risk factor prevalence at each examination and the multivariable-adjusted hazards ratio estimate for 10 years after each examination, derived from Cox proportional hazards models adjusting for all primary risk factors. All Cox models were also stratified by sex, race, study center, and age (ie, controlled for these 4 variables without requiring the standard proportional hazards assumption). We performed all analyses using STATA version 12.1 (College Station, TX), with a 2-tailed P value <0.05 considered statistically significant.
Results
The sample characteristics are shown in Table 1 and Table I in the online-only Data Supplement. Of the participants who contributed observations to this analysis, 56% were women and 26% were black. Mean body mass index slightly but significantly increased from the first to the fourth examination (P<0.001), and the proportion of individuals with obesity increased from 26% to 33% over this same time period (P<0.001). The frequencies of hypertension (39% to 45%) and diabetes mellitus (12% to 14%) also increased from the first to the fourth examination, whereas the frequencies of smoking (24% to 16%) and hypercholesterolemia (68% to 55%) decreased (P<0.001 for all).
The 10-year crude CVD event rate was 1.51 (95% confidence interval (CI), 1.43-1.60) per 100 person-years for middle-aged participants (52-66 years old) who attended the first examination in 1987 through 1989, with similar rates observed for those attending the second exam in 1990 through 1992 (1.59; 95% CI, 1.51-1.68), third exam in 1993 through 1995 (1.52; 95% CI, 1.44-1.61), and fourth exam in 1996 through 1998 (1.45; 95% CI, 1.36-1.55). For participants attending the initial 1987 to 1989 examination, crude 10-year event rates were higher with increasing number of CVD risk factors present: 0.8, 0.9, 1.6, 2.5, 4.4, and 7.5 per 100 person-years for individuals with 0 to 5 risk factors, respectively; this trend was similar across time (Table II in 
Temporal Trends by Sex
Sex-based variation in the estimated attributable risks for CVD existed initially in the late 1980s as well as subsequent time periods (Table 3 and Figure) . In analyses stratified by sex ( Figure I . Although more prevalent in women than men, the contribution of hypercholesterolemia to CVD risk was similar between the women and men at all exams. Except for obesity, the reason women often had higher PARs than men was because the hazard ratios for CVD tended to be greater for risk factors, rather than the prevalence of risk factors ( Figure II in the online-only Data Supplement).
Temporal Trends by Race
There were marked differences in the attributable risks for CVD between blacks and whites (Table 4 and Figure) . As show in Figure I this increase in diabetes mellitus-related CVD risk was driven by both increasing prevalence as well as increasing associated hazards (Table 4 and Figure III in the online-only Data Supplement). Hypercholesterolemia conferred similar risks in whites and blacks, although this contribution decreased over time in whites (PAR 0.22 versus 0.10; P=0.04). Although more prevalent in blacks than whites, contributions of obesity and smoking to CVD risk were not significantly different between races at all time points.
In secondary analyses conducted using a hard CHD end point (defined as including only hospitalized myocardial infarction or CHD death) as part of the composite CVD outcome, we observed results that were similar to those of the main analyses. These results were similar for the total sample as well as by sex and race (data not shown). In analyses repeated separately for each study center, we observed geographic variation that was not completely reflected by between-center differences in racial distributions (Table III in the online-only Data Supplement).
Discussion
We investigated temporal trends in the contributions of risk factors to CVD in a large multi-center and biracial community-based cohort, with clinical assessments conducted over 12 years and outcomes surveillance spanning more than 2 decades. We observed a trend of decreasing overall population risk attributable to traditional risk factors over time, largely as a result of the decreasing prevalence of hypercholesterolemia and smoking. However, the combined contribution of all traditional risk factors has remained substantially higher in women compared with men, and in blacks compared with whites. These sex-and race-based differences continue to be especially pronounced for hypertension and diabetes mellitus. Together, these data highlight the ongoing need for targeted risk factor modification despite recent improvements in the public health efforts to reduce the overall burden of CVD risk.
In our total study sample, the CVD risk attributable to all the 5 major traditional risk factors that we analyzed steadily decreased over the time period extending from the late 1980s through the last decade. These overall trends may be related to concomitant changes in the definitions of select CVD risk factors, and their effects on practice in the community, 16 along with increasing rates of treatment and control for select risk factors. 17 Specifically, we observed marked declines in the prevalence of hypercholesterolemia and particularly smoking, which have been reported previously. 17 Interestingly, the hazard associated with hypercholesterolemia also decreased, whereas the hazard associated with smoking actually increased over time. The trends observed for hypercholesterolemia may well have been related to substantially increased use of cholesterol-lowering medication over time in the population at large; further research is warranted to better understand time trends of the population risk attributable to statin use as well as other medications used to modify cardiovascular risk. These observations may also be related to birth cohort effects or differing dose-response relationships (not captured by the binary variables we studied) in the magnitude of CVD risk associated with having persistently high cholesterol or being an active smoker. Accordingly, with respect to hypertension, secular trends and improvements in blood pressure control are a likely explanation for the finding that the hazard associated with hypertension decreased even though hypertension prevalence increased over time. 8, 18 Although it is well known that the prevalence of obesity is increasing nationwide, 19, 20 we observed that the CVD risk attributable to obesity has remained relatively low as well as constant over time. It is possible that obesity may have longer term effects than could be seen within 10 years of follow up, 21 and that such longer term effects may well manifest as risk attributable to diabetes mellitus. Indeed, consistent with national and worldwide trends, 22 the overall prevalence of diabetes mellitus increased over the study period; this increase was associated with hazards for CVD that remained high overall, with some notable variations by subgroup.
We observed substantial differences between women and men in population attributable risks for CVD over time. At examination 1, the proportion of CVD risk attributable to all risk factors was significantly higher in women than men. Prior studies have noted similar sexual dimorphism in the attributable CVD risks associated with major risk factors such as hypertension and diabetes mellitus. [23] [24] [25] These sexbased differences may be related to the possibility that nontraditional risk factors contribute more to CVD in risk in men than women, or that women were historically less likely to have prevalent risk factors controlled. 26, 27 We observed that the overall sex difference in PARs had substantially narrowed by the late 1990s, potentially related to the success of public health effects aimed at increasing the awareness of CVD risk in women. 28 Indeed, prevalence of hypertension was higher in women than men in the late 1980s, and this difference decreased over time. However, women still tended to have more prevalent hypertension as well as a higher associated CVD risk, even by the late 1990s; this finding could be related to the greater proportion of isolated systolic hypertension and arterial stiffness in women than men. [29] [30] [31] Despite similar trends to men in the decreasing prevalence of smoking and increasing prevalence of obesity, women tended to display consistently higher hazards of CVD risk associated with both of these risk factors over time. Most importantly, the CVD risk attributable to diabetes mellitus remained significantly higher in women than men over time, driven by higher associated hazards despite lower prevalence rates. Prior studies have reported similar sex-based differences in the risks associated with smoking, 32 obesity, 33 and diabetes mellitus, [34] [35] [36] although without specifically examining temporal trends in both prevalence and associated hazards in the context of other risk factors. The reasons for persistent sex differences in attributable 37 and could be related to greater clustering of risk factors in women than men, 38, 39 continued under-recognition or undertreatment of prevalent risk factors in women, 28 or hormonal or nonhormonal biological variation that has yet to identified. 40 Additionally, men could have more inherent unexplained risk, which could be accounted for by nontraditional risk factors.
We also observed marked differences between blacks and whites in the temporal trends of population attributable risks for CVD. The risk attributable to all 5 traditional risk factors combined was higher in blacks than whites in the late 1980s, and this difference was even larger by the late 1990s, suggesting that efforts to improve CVD risk factor modification are not benefitting blacks as much as whites. The 2 primary contributors to race-based differences in CVD risk over time were hypertension and diabetes mellitus. The prevalence of hypertension increased in both blacks and whites, but both prevalence rates and associated hazards were consistently higher in blacks than whites at all exams. Race differences for diabetes mellitus were even more profound. In whites, the prevalence of diabetes mellitus remained constant while the associated hazard tended to decrease over time; in blacks, the prevalence of diabetes mellitus was consistently more than double that in whites and the diabetes mellitus-associated hazards actually increased over time in blacks. Consequently, the attributable CVD risk of diabetes mellitus was significantly higher in the late 1990s than a decade earlier in blacks. Although numerous previous studies have reported differences by race in the prevalence of CVD risk factors including hypertension and diabetes mellitus, 41 fewer have investigated race differences in associated hazards, [42] [43] [44] and none have previously examined race variation in both prevalence and hazards over time. Previous work in the ARIC cohort has noted that the proportion of CVD risk explained by traditional risk factors is much larger in blacks compared with whites, particularly when considering borderline risk factors 45 ; therefore, race-based differences over time may be even more pronounced when accounting for borderline clinical risk factors. Because the majority of blacks in this study were enrolled at the Jackson study center, it is important to note that our race-based analyses may have been particularly influenced by geography even in analyses stratified by study center. Notwithstanding the multiple additional socio-economic, clinical, and biological factors that may be implicated, 44 our results highlight the magnitude and trajectory of differences between blacks and whites in the contribution of risk factors to CVD.
Several limitations of the study merit consideration. Our composite CVD outcome included coronary revascularization events; although these procedures may have been performed less frequently in certain subgroups, the main study findings were similar for subgroups when analyses were repeated using the CVD outcome that did not include coronary revascularization. It is known that precision in the estimate of the PAR is suboptimal for highly prevalent exposures 15 ; thus, PAR estimates for very prevalent exposures within a given sample or subgroup should be interpreted with caution. Because PAR estimates can be calculated only for binary variables, we were not able to analyze continuous variables that may contribute residual CVD risk but are without widely established definitions of normal versus abnormal; thus, we focused on presence versus absence of traditional risk factors that are easily assessed and are also generally considered to be modifiable. Because we used conventional definitions for binary risk factor variables, PARs reported herein are lower than estimates that could be calculated using risk factor definitions based on "ideal" thresholds. 12 It is important to note that the PAR estimate provides a comparison between the observed data and a hypothetical scenario where a given risk factor has been eliminated; despite the impracticality of such an assumption, PAR estimates can provide a common scale for comparing the potential population-level impact of targeting interventions for preventing or treating a given risk factor. Although the time period studied was relatively short, it included an interval that captured major changes in risk factors. Indeed, the observed time trends are likely related to a combination of effects from aging, birth cohort differences, and secular changes that cannot be completely measured and accounted for in our models. In addition, sampling at the more recent exams may yet have been influenced by survivor bias. To facilitate comparisons across time intervals, we restricted analyses to a sample that was middle-aged as well as predominantly either white or black with respect to racial/ethnic group. Generalizability of our findings to other age and racial/ethnic groups or to populations beyond the 4 ARIC communities is unknown.
We examined the temporal trends in the attributable contributions of traditional risk factors to incident CVD in a large community-based cohort comprising middle-aged men and women, representing both blacks and whites. The overall PAR for all risk factors remains well over 50%, indicating that preventing or removing these risk factors might eliminate a large proportion of CVD in the community. In fact, if the whole population could maintain low risk status through primordial prevention, most CVD events might be prevented. 12, 20, 46, 47 Indeed, we observed that the overall 10-year rate of CVD in a middle-aged sample is ≈1.5 per 100 person-years, and among those with no major risk factors the CVD rate is only ≈0.7. In addition to persistently high PAR for the total sample, we observed that the contribution to incident CVD of all traditional risk factors combined is greater in blacks than whites, and this difference may be increasing with time. The risks attributable to hypertension and diabetes mellitus remain especially high, in women as well as blacks. Together, these findings underscore the continued need for individual as well as population approaches to CVD risk factor modification. 
Ascertainment of Outcomes
All participants were followed longitudinally through December 31, 2008 for the incidence of new cardiovascular events, ascertained according to previously defined criteria, and death. 1 Incident cardiovascular events included: coronary heart disease (CHD), heart failure (HF), and stroke. From a review of outside hospital records and ARIC clinic examination data, a CHD event was defined as a validated definite or probable hospitalized myocardial infarction (based on documented chest pain symptoms, electrocardiographic changes, and cardiac biomarker levels), a definite CHD death (based on chest pain symptoms, cause of death documented on the death certificate, and associated hospital and ARIC clinic information), electrocardiographic evidence of an unrecognized prior myocardial infarction (a major Q-wave, or a minor Q-wave with associated ST-T changes), or documented coronary revascularization. [2] [3] [4] Upon review of data from hospital discharge records and death certificates, incident HF was defined as hospitalization for HF (based on a combination of documented new or worsening HF signs and symptoms diagnostic tests indicating cardiac dysfunction, natriuretic peptide levels, and response to diuretic therapy) or death with presence of HF listed on the death certificate. 5, 6 Using data collected from hospital records and death certificates, incident stroke was defined as a validated definite or probable hospitalization for ischemic or hemorrhagic stroke (based on documented type of neurologic signs and symptoms, duration and severity of physical findings, and results of neuroimaging or other diagnostic procedures) or death with presence of stroke (stroke listed on the death certificate, and autopsy evidence when available).
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Statistical Analyses
We determined the means and frequencies of conventionally defined traditional cardiovascular risk factors for each study sample at examinations 1 through 4 (i.e. the 'baseline' examinations).
We used the 'population attributable risk' method, which relies on the relative risk and prevalence of a risk factor and allows estimation of the proportion of CVD risk in a population that can be attributed to the assumed effects of 1 or more risk factors. [8] [9] [10] [11] This method offers the ability to assess the relative importance of conventional risk factors (with respect to cardiovascular outcomes) over time. We defined presence versus absence of the primary risk exposures according to the criteria listed above for: obesity, hypertension, diabetes, hypercholesterolemia, and smoking status. We defined the primary dependent variable as the incidence of new-onset CVD within 10 years from each baseline examination. At each of the examinations, we estimated the PAR % (population attributable risk %) of each primary risk exposure for the 10-year incidence of CVD using a method that is considered internally valid when adjusted relative risks must be used to account for possible confounding: 8 
